Articles by Daniel Marsh
UiPath Shares Slide as Buyback Fails to Mask ARR Growth Concerns
UiPath shares dipped 1.2% to $10.15 as a $436.9 million buyback fails to alleviate concerns over 12% ARR growth and rising competition.
Allegiant Air Cuts 61 Routes, Shifts to Shorter Flights Amid High Fuel Costs
Allegiant Air is cutting 61 routes and reducing Q2 capacity by 6.5% as fuel costs rise to $4.35/gallon, shifting focus to shorter, more profitable flights. Shares rose 2.1% to $102.89.
Ford Shares Flat as Canadian Labor Talks Begin; Inventory Poses Pricing Risk
Ford shares hover around $14 as Unifor begins Canadian labor negotiations, while elevated F-Series inventory raises potential pricing concerns.
Palantir Hits 52-Week Low as AI Hype Fades, Valuation Under Scrutiny
Palantir Technologies fell over 6% to a 52-week low of $119.76 as AI software valuations come under pressure, despite strong U.S. revenue growth and a raised 2026 outlook.
SoFi Shares Dip 3.6% as CEO's Buying Average and Funding Costs Take Center Stage
SoFi Technologies (SOFI) shares slid 3.6% to $17.26, nearly matching CEO Anthony Noto's 2026 open-market buying average, as investors weighed insider buying and deposit funding strength.
Rocket Lab Drops 7% on Nasdaq-100 Debut Amid Dilution Fears and Space Selloff
Rocket Lab shares dropped 7.2% to $99.49 on its Nasdaq-100 debut, pressured by a $3 billion at-the-market stock sale program and a broader space sector decline.
Student Loan Autopay Discount Slashed Ahead of July Reset
Eligible federal Direct Loan borrowers will receive a temporary 1-point interest rate cut through autopay from July 1, 2026, to June 30, 2028, as new loan rates increase to between 6.52% and 9.07%.
AbbVie Acquires Apogee Therapeutics for $10.9B in Cash, Bolstering Pipeline
AbbVie announced a $10.9 billion cash acquisition of Apogee Therapeutics, adding a promising eczema treatment to its pipeline as it seeks to offset declining Humira sales.
Russell Index Overhaul: CoreWeave Joins Large-Cap, Bloom Energy Ascends
FTSE Russell's annual index reconstitution will trigger trillions in passive fund trades at Friday's close, with CoreWeave joining the Russell 1000 and Bloom Energy moving up, driving concentrated order flows.